Rallybio annual operating margin
2024
2025
Rallybio's operating margin was −3,853.61% for fiscal 2025.
View full Rallybio company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3,853.61% | +5658.34 pp |
| 2024 | 2024-12-31 | −9,511.95% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −4,119.34% | +441.98 pp |
| Q4 2025 | 2025-12-31 | −2,888.29% | +27659.08 pp |
| Q3 2025 | 2025-09-30 | −3,266.51% | +768.94 pp |
| Q2 2025 | 2025-06-30 | −4,743.87% | +953.46 pp |
| Q1 2025 | 2025-03-31 | −4,561.32% | — |
| Q4 2024 | 2024-12-31 | −30,547.37% | — |
| Q3 2024 | 2024-09-30 | −4,035.45% | — |
| Q2 2024 | 2024-06-30 | −5,697.32% | — |
Across the available reported history, Rallybio's operating margin increased from −9,511.95% to −3,853.61%, a change of +5658.34 percentage points. The latest reported quarter, Q1 2026, shows −4,119.34%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rallybio filings at SEC.gov ↗